Robert Letterio Oliva's most recent trade in Novo Integrated Sciences Inc was a trade of 5,000 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on April 19, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Integrated Sciences Inc | Robert Letterio Oliva | Director | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 19 Apr 2022 | 5,000 | 212,717 | - | 2.2 | 11,125 | Common Stock |
| Novo Integrated Sciences Inc | Robert Letterio Oliva | Director | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 19 Apr 2022 | 4,700 | 217,417 | - | 2.2 | 10,481 | Common Stock |
| Novo Integrated Sciences Inc | Robert Letterio Oliva | Director | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 19 Apr 2022 | 300 | 217,717 | - | 2.3 | 675 | Common Stock |
| Novo Integrated Sciences Inc | Robert Letterio Oliva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 93,995 | 93,995 | - | - | Stock Option (right to buy) | |
| Novo Integrated Sciences Inc | Robert Letterio Oliva | Director | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 21 Apr 2021 | 13,000 | 207,717 | - | 2.1 | 27,560 | Common Stock |
| Novo Integrated Sciences Inc | Robert Letterio Oliva | Director | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 22 Feb 2021 | 9,355 | 194,517 | - | 4.3 | 40,320 | Common Stock |
| Novo Integrated Sciences Inc | Robert Letterio Oliva | Director | Purchase of securities on an exchange or from another person at price $ 4.45 per share. | 22 Feb 2021 | 200 | 194,717 | - | 4.5 | 890 | Common Stock |